Leading Scottish University Joins ITI Life Sciences' Stem Cell Technologies R&D Programme
Dundee University to provide additional research expertise to progress SCT programme
ITI Life Sciences announced that it has reached its first technical milestone in its Stem Cell Technologies (SCT) R&D programme, and as a result Dundee University has joined the £9.5 million programme, which started in January 2007.
Dundee University will join the programme's other research providers, Swedish biotech firm Cellartis AB and the University of Glasgow, in a collaborative effort to develop technologies that will enable automated processes to produce high volumes of high quality human stem cells. This capability does not exist anywhere in the world and its development shall put Scotland at the forefront of stem cell research as well as bringing closer the use of stem cells as therapeutics.
The initial phase of the programme has focused on developing optimal conditions under which human embryonic stem (hES) cells can be tested (screened) for their ability to differentiate into specific cells. Having achieved this crucial step, ITI Life Sciences is now in a position to bring in Dundee University's complementary screening expertise, which shall be instrumental in developing additional technologies towards the programme's ultimate objectives.
Other news from the department science
